Related Experiment Video
Updated: Aug 9, 2026

Mutagenesis and Functional Selection Protocols for Directed Evolution of Proteins in E. coli
Published on: March 16, 2011
Positive R plasmid mutator effect on chromosomal mutation to nalidixic acid resistance in nalidixic acid-exposed
1Department of Pharmaceutics, School of Pharmacy, University of London, UK.
Abstract:
Mutation frequencies to nalidixic acid resistance (15 mg/L in nutrient agar) were determined for derivatives of Escherichia coli AB1157 carrying the mutator plasmids R46, R391 or pYD1, or the non-mutator plasmid RP4. Frequencies of mutation remained constant in cultures of AB1157(R46) growing exponentially in drug-free broth, at a level about 12-fold higher than in the strain without plasmid. Mutation frequencies in cultures of strains AB1157(R391) and AB1157(pYD1) were about three times greater than in the control, whereas plasmid RP4 had no effect on spontaneous mutation frequency to nalidixic acid resistance. Exposure of strain AB1157 to 6 mg/L nalidixic acid in nutrient broth killed 80% of cells after 4 h. This enriched the proportion of nalidixic acid-resistant cells present in the surviving cell population giving enhanced "apparent" mutation frequencies. These were further increased by cell division of resistant mutants in the nalidixic acid-containing medium. "Apparent" resistance mutation frequencies in nalidixic acid-exposed cultures of the R46-, R391- or pYD1-carrying derivatives were, at their peak, 447-, 53- and 38-fold higher than in the control, the strain without plasmid, or the RP4-containing strain, respectively. These data illustrate how mutator plasmids like R391 and pYD1, which mediate only small increases in spontaneous mutation, can contribute to the development of clinically-significant levels of quinolone resistance.
Insights
Mutator plasmids R46, R391, and pYD1 increase spontaneous mutation frequencies in Escherichia coli, contributing to quinolone resistance development. Even small increases in mutation rates can lead to clinically significant resistance levels.
Area of Science:
- Microbiology
- Genetics
- Molecular Biology
Background:
- Mutator plasmids can increase spontaneous mutation rates in bacteria.
- Quinolone resistance is a significant clinical concern.
- Understanding the genetic basis of bacterial resistance is crucial for public health.
Purpose of the Study:
- To investigate the effect of specific mutator plasmids (R46, R391, pYD1) on nalidixic acid resistance mutation frequencies in Escherichia coli.
- To determine if the non-mutator plasmid RP4 affects mutation rates.
- To assess how sub-lethal concentrations of nalidixic acid impact apparent mutation frequencies.
Main Methods:
- Determining mutation frequencies to nalidixic acid resistance in Escherichia coli AB1157 derivatives carrying different plasmids.
- Culturing strains in drug-free broth and in the presence of nalidixic acid.
- Analyzing mutation frequencies under exponential growth and after exposure to sub-lethal drug concentrations.
Main Results:
- Mutator plasmids R46, R391, and pYD1 increased spontaneous mutation frequencies to nalidixic acid resistance.
- Plasmid RP4 did not affect mutation frequencies.
- Exposure to nalidixic acid significantly enhanced apparent mutation frequencies, particularly in strains with mutator plasmids, reaching up to 447-fold higher than controls.
Conclusions:
- Mutator plasmids, even those with modest increases in spontaneous mutation, can contribute to the development of clinically significant quinolone resistance.
- Bacterial adaptation under antibiotic pressure can rapidly increase resistance levels.
- These findings highlight the role of mutator elements in bacterial evolution and antibiotic resistance.
Related Concept Videos
Antibiotic Selection
Stringent Response in E. coli
Mutations in Microorganisms
Plasmids
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA

